What Are The Key Clinical Features Of Seborrheic Keratosis (Sk), And How Should Practitioners Handle Them Before Energy-Based Skin Resurfacing? Avoid Risks With Proper Assessment

Seborrheic keratoses are common benign epidermal lesions with a characteristic “stuck-on” appearance, but they must be distinguished from melanoma and other malignancies before resurfacing. They are usually sharply demarcated, tan, brown, or black lesions measuring approximately 0.2 cm to more than 3 cm, with surfaces that may be smooth, verrucous, dry, or cracked. Before CO2 or Erbium laser resurfacing, microneedling radiofrequency, or other tissue-disruptive procedures, practitioners should assess the lesion clinically and dermoscopically and refer any atypical or suspicious lesion for dermatologic evaluation.

The key safety principle is simple: identify and document likely seborrheic keratoses, but do not ablate a lesion whose diagnosis is uncertain. Suspicious pigmentation, ulceration, induration, rapid growth, or other atypical features require dermatologic assessment, and potentially histologic confirmation, before aesthetic treatment.

Recognizing the Clinical Features of Seborrheic Keratosis

The Typical Appearance

Seborrheic keratoses are benign lesions confined to the epidermis. They are usually sharply outlined and appear as plaques or papules that seem to sit on top of the skin.

Their color ranges from tan and light brown to dark brown or black. A single patient may have lesions with different colors and surface textures.

The “Stuck-On” Quality

The classic clinical clue is a stuck-on appearance. Lesions may be smooth and waxy or dry, cracked, and verrucous.

This appearance reflects a superficial keratotic lesion rather than a growth extending deeply into the dermis. However, visual resemblance alone is not sufficient to exclude malignancy, particularly when the lesion is heavily pigmented.

Size, Thickness, and Surface

SKs can measure from approximately 0.2 cm to more than 3 cm. They may be thin and relatively flat or substantially raised and hyperkeratotic.

Thickness matters when planning treatment. A thin lesion may require limited superficial treatment, while a thicker lesion may need a different dermatologic removal strategy to avoid unnecessary thermal injury or pigmentary complications.

What Must Be Ruled Out Before Resurfacing

Melanoma and Dysplastic Nevi

Pigmented SKs can resemble cutaneous melanoma or dysplastic nevi. Color variation, asymmetry, irregular borders, recent change, or an unusual clinical pattern should increase the level of caution.

Aesthetic treatment should not be used as a diagnostic test. If the lesion is atypical or its identity is uncertain, treatment should be deferred and the patient referred to a dermatologist.

Squamous Cell Carcinoma and Actinic Lesions

Hyperkeratotic or scaly lesions on sun-damaged skin may also represent squamous cell carcinoma, actinic keratosis, or another premalignant or malignant process. Ulceration, induration, rapid expansion, bleeding, and marked inflammation are concerning features.

A lesion reported to be rapidly enlarging, particularly when it becomes larger than approximately 1 cm or develops ulceration or induration, warrants formal medical assessment before resurfacing.

Dermoscopic Assessment

When available and within the practitioner’s scope, dermoscopy can support recognition of benign SK features such as:

Horn pseudocysts
Comedo-like openings
Milia-like cysts
Keratin-filled openings
Regular epidermal ridges

These findings may support a benign diagnosis, but they do not eliminate the need for referral when the lesion remains clinically suspicious or diagnostically uncertain.

How Practitioners Should Assess the Patient

Examine the Entire Treatment Area

The assessment should include the full planned treatment zone, not only the most obvious lesion. Document the lesion’s location, size, color, border, surface, and thickness.

Photographic documentation can help establish a baseline and identify lesions that have changed since a previous consultation.

Review Cancer and Skin-History Factors

Ask about previous skin cancers, atypical nevi, changing pigmented lesions, immunosuppression, and recent changes such as bleeding, crusting, pain, or rapid growth.

Patients with extensive photodamage may have visible and subclinical precancerous changes that are not appropriate targets for routine cosmetic ablation without proper medical evaluation.

Consider Procedure-Related Risk Factors

Before superficial resurfacing, also assess factors that can increase complications:

Higher Fitzpatrick skin types or a history of post-inflammatory hyperpigmentation
Personal or family history of keloid or hypertrophic scar formation
Recent intense sun exposure or tanning
Highly reactive, inflamed, or sensitized skin
Delayed wound healing or other relevant medical risks

These factors do not diagnose an SK, but they influence whether and how resurfacing should be performed.

Handling SKs Before Energy-Based Resurfacing

Do Not Treat Uncertainty as Benign

A practitioner should avoid applying fractional CO2, Erbium, microneedling RF, or comparable energy directly over a lesion that has not been adequately assessed.

If the lesion is suspicious, changing, unusually asymmetric, ulcerated, indurated, or difficult to distinguish from melanoma or another malignancy, postpone the aesthetic procedure and arrange dermatologic evaluation.

Map or Avoid Known Lesions

When an SK has been clinically assessed as benign, the practitioner should document and map it before treatment. Depending on the protocol and device, the lesion may be deliberately avoided or treated only under an appropriate lesion-management plan.

The fact that SKs are epidermal does not mean every device or setting is automatically appropriate. Energy delivery must still be controlled to prevent unnecessary injury to surrounding skin.

Refer Before Ablation or Removal

If the treatment plan involves laser ablation, cryosurgery, curettage, or another method intended to remove a pigmented lesion, diagnostic confidence is essential.

A dermatologist should evaluate lesions that are suspicious, atypical, recurrent, or diagnostically unclear. Histology may be required before destruction because ablating a malignant lesion can delay diagnosis and compromise subsequent assessment.

Understanding the Trade-offs

Treating Thick Lesions Too Aggressively

Thicker or raised SKs may not respond predictably to brief superficial energy delivery. Increasing energy to compensate can cause excessive peripheral hyperpigmentation, prolonged inflammation, or deeper thermal injury.

Lesion thickness should therefore guide treatment selection. In some cases, superficial ablation combined with curettage is used, but this should be performed only within appropriate clinical expertise and after malignancy has been excluded.

Relying on Color Alone

Dark pigmentation is not proof of melanoma, and a tan or brown color does not prove that a lesion is benign. Color must be interpreted together with border, symmetry, surface characteristics, evolution, and dermoscopic findings.

A “stuck-on” appearance is helpful but not definitive when the lesion is atypical or changing.

Overlooking Scar and Pigment Risk

Even a correctly identified SK can be followed by prolonged erythema, pigment alteration, or scarring after epidermal disruption. These risks are higher in patients prone to PIH, those with darker skin types, and those with a history of abnormal scarring.

Treatment parameters and the decision to treat should account for the patient’s healing history, not only the lesion’s superficial location.

Making the Right Choice for Your Goal

The appropriate workflow is to establish diagnostic confidence first, then decide whether resurfacing should avoid, separately manage, or defer treatment of the lesion.

If your primary focus is diagnostic safety: Document each suspicious or atypical lesion and refer it for dermatologic evaluation before applying energy or performing destructive treatment.
If your primary focus is cosmetic resurfacing: Map clinically benign SKs, avoid unnecessary energy delivery over them, and select conservative parameters based on lesion thickness, skin type, and healing risk.
If your primary focus is lesion removal: Confirm that the lesion is suitable for removal and use an appropriate dermatologic treatment plan rather than assuming a resurfacing device is sufficient.
If your primary focus is complication prevention: Screen for PIH risk, recent sun exposure, reactive skin, keloids, and hypertrophic scars before proceeding.

A careful diagnosis-first assessment allows practitioners to protect patient safety while selecting the least aggressive effective resurfacing approach.

Summary Table:

Feature	Clinical Presentation	Implications for Resurfacing
Typical appearance	Sharply demarcated, tan to black, stuck-on look	Usually benign; document and map
Surface	Smooth, waxy, verrucous, or cracked	Thicker lesions may need different approach
Size	0.2 cm to >3 cm	Larger lesions may be more concerning
Mimics melanoma	Atypical pigmentation, irregular borders, change	Refer for dermatologic evaluation
Mimics SCC	Ulceration, induration, rapid growth	Defer treatment and refer
Dermoscopic features	Horn pseudocysts, comedo-like openings	Supports benign diagnosis, but not definitive
Pigment risk	Darker skin types, PIH history	Adjust parameters; consider conservative treatment
Scarring risk	Keloid history, hypertrophic scarring	Avoid or modify treatment

Ensure your patients' safety and achieve optimal resurfacing outcomes with BELIS professional-grade equipment. Our advanced laser systems (Diode, Alexandrite, CO2 Fractional, Erbium, Nd:YAG, Pico) and RF devices are designed for precise, controlled treatment, helping you manage SKs effectively. Partner with BELIS for reliable technology and comprehensive support. Contact us today to learn more!